GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo International PLC (LTS:0Y5F) » Definitions » Other Long-Term Liabilities

Endo International (LTS:0Y5F) Other Long-Term Liabilities : $11,176 Mil (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Endo International Other Long-Term Liabilities?

Endo International's other long-term liabilities for the quarter that ended in Dec. 2023 was $11,176 Mil.

Endo International's quarterly other long-term liabilities declined from Jun. 2023 ($8,965 Mil) to Sep. 2023 ($1,447 Mil) but then increased from Sep. 2023 ($1,447 Mil) to Dec. 2023 ($11,176 Mil).

Endo International's annual other long-term liabilities increased from Dec. 2021 ($277 Mil) to Dec. 2022 ($9,212 Mil) and increased from Dec. 2022 ($9,212 Mil) to Dec. 2023 ($11,176 Mil).

Endo International Other Long-Term Liabilities Historical Data

The historical data trend for Endo International's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo International Other Long-Term Liabilities Chart

Endo International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Endo International Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Endo International Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Endo International Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Endo International's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Endo International (LTS:0Y5F) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo International PLC (LTS:0Y5F) » Definitions » Other Long-Term Liabilities
Comparable Companies
DVLP STMH THCT BBBT NEPTF BLMS HCANF INLB BGPPF DMKPQ ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
N/A
Address
Simmonscourt Road, Ballsbridge, First Floor, Minerva House, Dublin, IRL, 4
Website
https://www.endo.com
Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. The company generates maximum revenue from the Branded Pharmaceuticals segment. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL.

Endo International (LTS:0Y5F) Headlines

No Headlines